{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:44:19Z","timestamp":1791474259648,"version":"4.3.4"},"reference-count":206,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.genhosppsych.2013.03.018","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T04:01:53Z","timestamp":1367812913000},"page":"398-406","source":"Crossref","is-referenced-by-count":138,"title":["A review of the interplay between tuberculosis and mental health"],"prefix":"10.1016","volume":"35","author":[{"given":"Anne M.","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"O\u2019Dywer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0005","first-page":"13","article-title":"A review of physical and mental health in homeless persons","volume":"29","author":"Martens","year":"2001","journal-title":"Public Health Rev"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1176\/ps.48.6.833","article-title":"Tuberculosis infection among people with severe mental illness","volume":"48","author":"McQuistion","year":"1997","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.151.1.151b","article-title":"Tuberculosis and the severely mentally ill","volume":"151","author":"Lopez","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2105\/AJPH.86.9.1318","article-title":"Tuberculosis and HIV among mentally ill men in a New York City shelter","volume":"86","author":"Saez","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.126.4.346","article-title":"Depression in medical in-patients","volume":"126","author":"Moffic","year":"1975","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0163-8343(83)90038-5","article-title":"The prevalence of emotional and cognitive dysfunction in a general medical population: using the MMSE, GHQ, and BDI","volume":"5","author":"Von Ammon Cavanaugh","year":"1983","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"10.1016\/j.genhosppsych.2013.03.018_bb0035","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/0277-9536(92)90184-R","article-title":"Depression and self-esteem: rapid screening for depression in black, low literacy, hospitalized tuberculosis patients","volume":"35","author":"Westaway","year":"1992","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3999(98)00006-3","article-title":"Demographic\/socioeconomic factors in mental disorders associated with tuberculosis in southwest Nigeria","volume":"45","author":"Aghanwa","year":"1998","journal-title":"J Psychosom Res"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0045","first-page":"749","article-title":"Psychiatric issues in the management of patients with multidrug-resistant tuberculosis","volume":"8","author":"Vega","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.genhosppsych.2013.03.018_bb0050","first-page":"703","article-title":"Co-morbid anxiety and depression among pulmonary tuberculosis patients","volume":"20","author":"Aamir","year":"2010","journal-title":"J Coll Phys Surg Pakistan"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2334-10-201","article-title":"Common mental disorders in TB\/HIV co-infected patients in Ethiopia","volume":"10","author":"Deribew","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.genhosppsych.2013.03.018_bb0060","first-page":"227","article-title":"The problem of tuberculosis in psychotics","volume":"50","author":"Balter","year":"1954","journal-title":"J Ark Med Soc"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-859X-7-7","article-title":"A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases","volume":"7","author":"Moussas","year":"2008","journal-title":"Ann Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.genhosppsych.2013.03.018_bb0080","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.genhosppsych.2013.03.018_bb0085","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.200512-1953OC","article-title":"Weekly rifapentine\/isoniazid or daily rifampin\/pyrazinamide for latent tuberculosis in household contacts","volume":"173","author":"Schechter","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"48","key":"10.1016\/j.genhosppsych.2013.03.018_bb0090","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"Jereb","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep CDC"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0095","first-page":"450","article-title":"Antituberculosis drug-resistance surveillance as a tool for tuberculosis control programmes: a retrospective study","volume":"52","author":"La Raja","year":"1997","journal-title":"Monaldi Arch Chest Dis"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003495-199958040-00005","article-title":"Treatment and prevention of multidrug-resistant tuberculosis","volume":"58","author":"Bastian","year":"1999","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00208-3","article-title":"A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users","volume":"66","author":"Batki","year":"2002","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0110","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1176\/ps.50.11.1389","article-title":"Can psychiatry learn from tuberculosis treatment?","volume":"50","author":"Torrey","year":"1999","journal-title":"Psychiatr Serv"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4088\/PCC.v03n0610","article-title":"Treatment of comorbid tuberculosis and depression","volume":"3","author":"Trenton","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-0179-4-4","article-title":"The relationship between anxiety, depression and illness perception in tuberculosis patients in Pakistan","volume":"4","author":"Husain","year":"2008","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-8343(01)00116-5","article-title":"Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12","volume":"23","author":"Aydin","year":"2001","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0130","first-page":"1198","article-title":"Chronic dyspnea and suicide in elderly men","volume":"43","author":"Horton-Deuth","year":"1992","journal-title":"Hosp Community Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0135","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1017\/S1041610209990378","article-title":"A preliminary cross-national study of a possible relationship between elderly suicide rates and tuberculosis","volume":"21","author":"Shah","year":"2009","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/nur.20074","article-title":"Predictors of screening results for depressive symptoms among homeless adults in Los Angeles with latent tuberculosis","volume":"28","author":"Berg","year":"2005","journal-title":"Res Nurs Health"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.psy.43.1.82-a","article-title":"Psychiatric symptoms in a case of intracranial tuberculosis","volume":"43","author":"Woodroof","year":"2002","journal-title":"Psychosomatics"},{"issue":"8","key":"10.1016\/j.genhosppsych.2013.03.018_bb0150","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/jnnp.41.8.730","article-title":"Intracranial space-occupying masses in mental hospital patients: necropsy study","volume":"41","author":"Cole","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000013407","article-title":"Cerebral tuberculoma 11 years after renal transplantation","volume":"18","author":"Mrowka","year":"1998","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0160","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1600-0447.2005.00606.x","article-title":"Tuberculous meningitis masked by delirium in an alcohol-dependent patient: a case report","volume":"112","author":"Jebaraj","year":"2005","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0165","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/ndt\/gfl009","article-title":"Uraemia, psychosis, young patient: an uncommon link Urinary tract and miliary tuberculosis","volume":"21","author":"Wagenlehner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0170","first-page":"663","article-title":"Panic disorder with agoraphobia following tuberculous meningitis","volume":"37","author":"Chand","year":"1996","journal-title":"Singapore Med J"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/02688690120114278","article-title":"Frontal lobe tuberculoma masquerading as postnatal depression","volume":"16","author":"Stavrou","year":"2002","journal-title":"Br J Neurosurg"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/tropej\/fmp080","article-title":"Behaviour profiles after tuberculous meningitis","volume":"56","author":"Wait","year":"2010","journal-title":"J Trop Pediatr"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0185","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/MJT.0b013e3181c0806d","article-title":"Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran","volume":"18","author":"Baghaei","year":"2011","journal-title":"Am J Ther"},{"issue":"7","key":"10.1016\/j.genhosppsych.2013.03.018_bb0190","first-page":"648","article-title":"Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis","volume":"5","author":"Furin","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0924-9338(03)00091-9","article-title":"Ciprofloxacin-induced acute psychosis in a patient with multidrug-resistant tuberculosis","volume":"18","author":"Norra","year":"2003","journal-title":"Eur Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.genhosppsych.2013.03.018_bb0200","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/106002809202600716","article-title":"Ciprofloxacin-induced psychosis","volume":"26","author":"Reeves","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.psy.48.3.269","article-title":"A case of ciprofloxacin-induced acute polymorphic psychosis with a distinct deficit in executive functions","volume":"48","author":"Grimm","year":"2007","journal-title":"Psychosomatics"},{"issue":"869","key":"10.1016\/j.genhosppsych.2013.03.018_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/pgmj.74.869.189","article-title":"Acute psychosis in a trauma patient due to ciprofloxacin","volume":"74","author":"James","year":"1998","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0215","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0090-4295(99)80171-X","article-title":"Ciprofloxacin-induced acute psychosis","volume":"46","author":"Mulhall","year":"1995","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0220","first-page":"665","article-title":"Acute psychosis following the use of topical ciprofloxacin","volume":"120","author":"Tripathi","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0225","first-page":"1053","article-title":"Psychotoxic reaction during ethionamide therapy","volume":"95","author":"Lansdown","year":"1967","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0041-3879(72)90031-1","article-title":"Acute psychotic reaction probably caused by ethionamide","volume":"53","author":"Narang","year":"1972","journal-title":"Tubercle"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0235","first-page":"537","article-title":"Candida. Rifampicin induced flu-syndrome and toxic psychosis","volume":"64","author":"Salafia","year":"1992","journal-title":"Indian J Leprosy"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0240","first-page":"406","article-title":"Psychiatric side effects of non-psychiatric drugs","volume":"3","author":"Editorial Enal","year":"1971","journal-title":"Sem Psyciatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000441-195701000-00011","article-title":"Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients","volume":"233","author":"Cohn","year":"1957","journal-title":"Am J Med Sci"},{"issue":"5047","key":"10.1016\/j.genhosppsych.2013.03.018_bb0250","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bmj.2.5047.743","article-title":"Psychosis due to isoniazid","volume":"2","author":"Jackson","year":"1957","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb0255","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1345\/aph.17377","article-title":"Isoniazid-induced psychosis","volume":"32","author":"Alao","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0260","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0033-3182(09)70872-2","article-title":"Isoniazid-induced psychosis","volume":"50","author":"Schrestha","year":"2009","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0265","first-page":"67","article-title":"Psychosis due to isoniazid","volume":"16","author":"Mengistu","year":"1978","journal-title":"Ethiop Med J"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/106002809302700205","article-title":"Isoniazid-associated psychosis: case report and review of the literature","volume":"27","author":"Pallone","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006565-200202000-00008","article-title":"Suicidal psychosis secondary to isoniazid","volume":"18","author":"Iannaccone","year":"2002","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.genhosppsych.2006.10.010","article-title":"Isoniazid-associated psychosis","volume":"29","author":"Witkowski","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0285","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/j.1440-1614.2000.0719i.x","article-title":"Novel antipsychotic drugs and INH-related psychosis","volume":"34","author":"Duggal","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/milmed\/161.11.707","article-title":"Psychotic disorder associated with isoniazid","volume":"161","author":"Bourgeois","year":"1996","journal-title":"Mil Med"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0295","first-page":"799","article-title":"Toxic psychosis due to isoniazid; report of three cases with studies of patterns of isoniazid inactivation in the serum","volume":"79","author":"Organick","year":"1959","journal-title":"Am Rev Tuberc"},{"issue":"2(8654)","key":"10.1016\/j.genhosppsych.2013.03.018_bb0300","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(89)90344-9","article-title":"Psychosis and anti-tuberculosis therapy","volume":"8","author":"Ball","year":"1989","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0305","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/106002809402801131","article-title":"Comment: isoniazid-induced psychosis","volume":"28","author":"Ibrahim","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0007-0971(62)80045-X","article-title":"Toxic psychosis due to isoniazid","volume":"56","author":"Duncan","year":"1962","journal-title":"Br J Dis Chest"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0315","first-page":"1498","article-title":"Mental disorders caused by isonicotinic acid hydrazide (INH) in the course of treatment of pulmonary tuberculosis","volume":"9","author":"Wasik","year":"1970","journal-title":"Pol Med J"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0320","first-page":"95","article-title":"Homicide by a tuberculous prisoner possibly having drug-induced acute delusional psychosis","volume":"44","author":"Tiwari","year":"1997","journal-title":"Indian J Tuberc"},{"issue":"10","key":"10.1016\/j.genhosppsych.2013.03.018_bb0325","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1345\/aph.19022","article-title":"Pyridoxine ineffective in isoniazid-induced psychosis","volume":"33","author":"Chan","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0330","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1258\/095646207780658863","article-title":"Ethambutol toxicity manifesting as acute onset psychosis","volume":"18","author":"Martin","year":"2007","journal-title":"Int J STD AIDS"},{"issue":"10","key":"10.1016\/j.genhosppsych.2013.03.018_bb0335","first-page":"724","article-title":"Ethambutol-induced psychosis: a case report","volume":"62","author":"Hsu","year":"1999","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0340","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0041-3879(79)90019-9","article-title":"Toxic psychosis to isoniazid and ethionamide in a patient with pulmonary tuberculosis","volume":"60","author":"Sharma","year":"1979","journal-title":"Tubercle"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0345","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1378\/chest.27.5.558","article-title":"Mental changes observed in 152 psychotic and non-psychotic patients during INH medication","volume":"27","author":"Rosenfeld","year":"1955","journal-title":"Dis Chest"},{"issue":"22","key":"10.1016\/j.genhosppsych.2013.03.018_bb0350","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.1979.03290480055027","article-title":"Rifampin-induced organic brain syndrome","volume":"241","author":"Pratt","year":"1979","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/1817-1737.43083","article-title":"Isoniazid- and ethambutol-induced psychosis","volume":"3","author":"Prasad","year":"2008","journal-title":"Ann Thorac Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0041-3879(89)90041-X","article-title":"Attempted suicide following treatment with isoniazid","volume":"70","author":"Madan","year":"1989","journal-title":"Tubercle"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0365","first-page":"222","article-title":"Intentional overdosage with isoniazid: case report and review of literature","volume":"37","author":"Tai","year":"1996","journal-title":"Singapore Med J"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0370","first-page":"125","article-title":"Toxic psychosis due to overdosage of isonicotinic acid hydrazide","volume":"49","author":"Chu","year":"1953","journal-title":"West Viriginia Med J"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0375","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1378\/chest.93.4.803","article-title":"Intentional isoniazid overdosage in young Southeast Asian refugee women","volume":"93","author":"Nolan","year":"1988","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.genhosppsych.2013.03.018_bb0380","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1001\/jama.1986.03380220097030","article-title":"Isoniazid overdose in the Cambodian population of Olmsted County, Minnesota","volume":"256","author":"Blanchard","year":"1986","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0385","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/ajp.132.6.662","article-title":"Intentional isoniazid overdosage among southwestern American Indians","volume":"132","author":"Sievers","year":"1975","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0736-4679(97)00242-4","article-title":"Isoniazid poisonings in New York City","volume":"16","author":"Sullivan","year":"1998","journal-title":"J Emerg Med"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0395","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jama.1966.03100060062019","article-title":"Suicide among patients with cardiorespiratory illnesses","volume":"195","author":"Farberow","year":"1966","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0400","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2466\/pr0.2001.89.2.326","article-title":"Tuberculosis and suicide","volume":"89","author":"Kondrichin","year":"2001","journal-title":"Psychol Rep"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0405","first-page":"220","article-title":"Side effects of cycloserine","volume":"71","author":"Helmy","year":"1970","journal-title":"Scand J Respir Dis Suppl"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0410","first-page":"201","article-title":"Neurologic and behavioural reactions of tuberculous patients treated with cycloserine","volume":"71","author":"Pasargiklian","year":"1970","journal-title":"Scand J Respir Dis Suppl"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0415","first-page":"306","article-title":"Clinical and laboratory experiences with cycloserine","volume":"71","author":"Jancik","year":"1970","journal-title":"Scand J Respir Dis Suppl"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0420","first-page":"35","article-title":"Psychosis associated with cycloserine","volume":"93","author":"Bankier","year":"1965","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0425","first-page":"235","article-title":"An autopsy case of cycloserine poisoning","volume":"31","author":"Miyakawa","year":"1977","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0430","first-page":"256","article-title":"Suicide of two patients during the postoperative course after pulmonary resection: possible effect of cycloserine","volume":"71","author":"Esteves","year":"1970","journal-title":"Scand J Respir Dis Suppl"},{"issue":"8","key":"10.1016\/j.genhosppsych.2013.03.018_bb0435","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/11534340-000000000-00000","article-title":"Nervous system effects of antituberculosis therapy","volume":"24","author":"Kass","year":"2010","journal-title":"CNS Drugs"},{"issue":"1\u20133","key":"10.1016\/j.genhosppsych.2013.03.018_bb0440","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2011.05.029","article-title":"D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia","volume":"131","author":"Gottlieb","year":"2011","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0445","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0450","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia","volume":"55","author":"Tsai","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2013.03.018_bb0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-9964(01)00220-1","article-title":"D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia","volume":"56","author":"Evins","year":"2002","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"10.1016\/j.genhosppsych.2013.03.018_bb0460","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.schres.2004.03.013","article-title":"Effects of D-cycloserine on negative symptoms in schizophrenia","volume":"71","author":"Duncan","year":"2004","journal-title":"Schizophr Res"},{"issue":"12","key":"10.1016\/j.genhosppsych.2013.03.018_bb0465","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0006-3223(96)00311-3","article-title":"Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients","volume":"40","author":"van Berckel","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0470","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pscychresns.2004.11.006","article-title":"Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine","volume":"138","author":"Yurgelun-Todd","year":"2005","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0475","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/106002809603000205","article-title":"Association of a Tourette-like syndrome with ofloxacin","volume":"30","author":"Thomas","year":"1996","journal-title":"Ann Pharmacother"},{"issue":"Suppl. 2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0480","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","article-title":"Antimicrobial safety: focus on fluoroquinolones","volume":"41","author":"Owens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0485","series-title":"Psychotropic Drug Directory 2012: the professionals' pocket handbook and aid memoire","author":"Bazire","year":"2012"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0490","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200225020-00005","article-title":"Clinically significant interactions with drugs used in the treatment of tuberculosis","volume":"25","author":"Yew","year":"2002","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0006-2952(68)90163-9","article-title":"Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo","volume":"17","author":"Robinson","year":"1968","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"10.1016\/j.genhosppsych.2013.03.018_bb0500","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/ajhp\/52.19.2135","article-title":"Potential interaction between isoniazid and selective serotonin-reuptake inhibitors","volume":"52","author":"Evans","year":"1995","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0505","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4088\/JCP.v57n1109g","article-title":"Coadministration of isoniazid and antidepressant drugs","volume":"57","author":"Malek-Ahmadi","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0510","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004850-199400920-00009","article-title":"Isoniazid and antidepressants: is there cause for concern?","volume":"9","author":"Judd","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"issue":"12","key":"10.1016\/j.genhosppsych.2013.03.018_bb0515","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/milmed\/166.12.1054","article-title":"Selective serotonin reuptake inhibitors and isoniazid: evidence of a potential adverse interaction","volume":"166","author":"Doyle","year":"2001","journal-title":"Mil Med"},{"issue":"18","key":"10.1016\/j.genhosppsych.2013.03.018_bb0520","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ajhp\/53.18.2217","article-title":"Lack of clinical evidence for potential interaction between isoniazid and selective serotonin-reuptake inhibitors","volume":"53","author":"Stockley","year":"1996","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl 1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199700321-00003","article-title":"Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism","volume":"32","author":"Preskorn","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0530","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A","volume":"45","author":"Desta","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00007691-199302000-00002","article-title":"Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms","volume":"15","author":"Sindrup","year":"1993","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0540","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004714-199608000-00006","article-title":"A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation","volume":"16","author":"Baumann","year":"1996","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0545","first-page":"927","article-title":"Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes","volume":"280","author":"Kobayashi","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0550","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00007691-199302000-00003","article-title":"Citalopram: interaction studies with levomepromazine, imipramine, and lithium","volume":"15","author":"Gram","year":"1993","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0555","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-199834040-00002","article-title":"Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications","volume":"34","author":"Caccia","year":"1998","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.genhosppsych.2013.03.018_bb0560","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0149-2918(08)80047-1","article-title":"Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update","volume":"30","author":"Spina","year":"2008","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.genhosppsych.2013.03.018_bb0565","first-page":"603","article-title":"Acute liver failure caused by isoniazid in a child receiving carbamazepine","volume":"2","author":"Berkowitz","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0570","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1378\/chest.99.6.1554a","article-title":"Interaction between carbamazepine and antituberculosis agents","volume":"99","author":"Fleenor","year":"1991","journal-title":"Chest"},{"issue":"6337","key":"10.1016\/j.genhosppsych.2013.03.018_bb0575","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bmj.285.6337.261","article-title":"Carbamazepine intoxication caused by interaction with isoniazid","volume":"285","author":"Valsalan","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"21","key":"10.1016\/j.genhosppsych.2013.03.018_bb0580","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM198211183072107","article-title":"Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction","volume":"307","author":"Wright","year":"1982","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0585","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejim.2004.07.005","article-title":"Isoniazid-induced hyperacute liver failure in a young patient receiving carbamazepine","volume":"15","author":"Campos-Franco","year":"2004","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0590","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00280078","article-title":"Interaction between isoniazid and valproate: a case of valproate overdosage","volume":"40","author":"Jonville","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"issue":"8551","key":"10.1016\/j.genhosppsych.2013.03.018_bb0595","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(87)92347-6","article-title":"Isoniazid-induced valproic-acid toxicity, or vice versa","volume":"2","author":"Dockweiler","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0600","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00002826-198608000-00006","article-title":"Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis","volume":"9","author":"Takeda","year":"1986","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0605","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/clpt.1981.94","article-title":"Diazepam interaction with antituberculosis drugs","volume":"29","author":"Ochs","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0610","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2125.1983.tb02256.x","article-title":"Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation","volume":"16","author":"Ochs","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0615","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10408363.2011.620601","article-title":"Methadone: a review of drug-drug and pathophysiological interactions","volume":"48","author":"Kapur","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0620","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2190\/KBVT-M0K5-8FPD-439H","article-title":"Drug interaction between rifampin and nortriptyline: a case report","volume":"21","author":"Bebchuk","year":"1991","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0625","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00000441-199602000-00004","article-title":"Case report: interaction of rifampin and nortriptyline","volume":"311","author":"Self","year":"1996","journal-title":"Am J Med Sci"},{"issue":"21","key":"10.1016\/j.genhosppsych.2013.03.018_bb0630","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1001\/archinte.1997.00440420085007","article-title":"Update on rifampin drug interactions III","volume":"157","author":"Strayhorn","year":"1997","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0635","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004714-200002000-00023","article-title":"Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline","volume":"20","author":"Markowitz","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0640","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-199606000-00010","article-title":"Effect of rifampin on the plasma concentration and the clinical effect of haloperidol concomitantly administered to schizophrenic patients","volume":"16","author":"Kim","year":"1996","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0645","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004714-199802000-00015","article-title":"Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection","volume":"18","author":"Joos","year":"1998","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0650","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.genhosppsych.2007.02.004","article-title":"Clozapine-rifampicin interaction in a patient with pulmonary tuberculosis","volume":"29","author":"Peritogiannis","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0655","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0091270007309888","article-title":"Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone","volume":"48","author":"Kim","year":"2008","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0660","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2710.2007.00811.x","article-title":"Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers","volume":"32","author":"Mahatthanatrakul","year":"2007","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0665","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3346\/jkms.2008.23.4.734","article-title":"Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient","volume":"23","author":"Shim","year":"2008","journal-title":"J Korean Med Sci"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb0670","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin : clinical relevance","volume":"42","author":"Niemi","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"20","key":"10.1016\/j.genhosppsych.2013.03.018_bb0675","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJM197605132942008","article-title":"Rifampin-induced methadone withdrawal","volume":"294","author":"Kreek","year":"1976","journal-title":"N Engl J Med"},{"issue":"8023","key":"10.1016\/j.genhosppsych.2013.03.018_bb0680","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(77)92756-8","article-title":"Rifampicin and methadone withdrawal","volume":"1","author":"Bending","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0685","first-page":"59","article-title":"Outbreak of multidrug-resistant tuberculosis at a methadone treatment program","volume":"5","author":"Conover","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0690","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1399-6576.2008.01867.x","article-title":"Interaction between rifampicin and methadone","volume":"53","author":"le Polain de","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0695","first-page":"443","article-title":"Rifampin-induced methadone withdrawal in AIDS","volume":"10","author":"Holmes","year":"1990","journal-title":"J Clin Psychopharmacol"},{"issue":"7062","key":"10.1016\/j.genhosppsych.2013.03.018_bb0700","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bmj.313.7062.925","article-title":"Methadone maintenance and tuberculosis treatment","volume":"313","author":"Raistrick","year":"1996","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0705","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1369-1600.2000.tb00197.x","article-title":"Ofloxacin causes false-positive immunoassay results for urine opiates","volume":"5","author":"Backmund","year":"2000","journal-title":"Addict Biol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0710","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1176\/appi.ajp.159.5.874","article-title":"Antituberculosis agents and carbamazepine","volume":"159","author":"Zolezzi","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0715","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.2006.02587.x","article-title":"Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements","volume":"62","author":"Owen","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0720","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002280000146","article-title":"Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects","volume":"56","author":"Ebert","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0725","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/clpt.1987.125","article-title":"The effect of antipyrine and rifampin on the metabolism of diazepam","volume":"42","author":"Ohnhaus","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0730","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s002280050420","article-title":"The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin","volume":"54","author":"Backman","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0735","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-9236(96)90018-1","article-title":"Rifampin drastically reduces plasma concentrations and effects of oral midazolam","volume":"59","author":"Backman","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0740","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(97)90176-4","article-title":"Triazolam is ineffective in patients taking rifampin","volume":"61","author":"Villikka","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb0745","first-page":"387","article-title":"Comparative effects of rifampin and\/or probenecid on the pharmacokinetics of temazepam and nitrazepam","volume":"28","author":"Brockmeyer","year":"1990","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0750","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/01213011-199912000-00007","article-title":"Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeine","volume":"9","author":"Schmider","year":"1999","journal-title":"Pharmacogenetics"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0755","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1997.00579.x","article-title":"Concentrations and effects of zopiclone are greatly reduced by rifampicin","volume":"43","author":"Villikka","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0760","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0009-9236(97)90082-5","article-title":"Rifampin reduces plasma concentrations and effects of zolpidem","volume":"62","author":"Villikka","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.genhosppsych.2013.03.018_bb0765","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00023210-200317070-00004","article-title":"Clinically important drug interactions with zopiclone, zolpidem and zaleplon","volume":"17","author":"Hesse","year":"2003","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0770","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0773.1999.tb00880.x","article-title":"Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone","volume":"84","author":"Kivisto","year":"1999","journal-title":"Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0775","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2125.1998.t01-1-00698.x","article-title":"Concentrations and effects of buspirone are considerably reduced by rifampicin","volume":"45","author":"Lamberg","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0780","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jinf.2005.04.007","article-title":"Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)\u2013a report of ten cases","volume":"52","author":"von der Lippe","year":"2006","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb0785","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1086\/374558","article-title":"Serotonin syndrome after concomitant treatment with linezolid and citalopram","volume":"36","author":"Bernard","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0790","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/375689","article-title":"Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients","volume":"37","author":"Hachem","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0795","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11845-010-0597-9","article-title":"Serotonin syndrome in an orthopaedic patient secondary to linezolid therapy for MRSA infection","volume":"180","author":"McClean","year":"2011","journal-title":"Ir J Med Sci"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0800","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1525-8610(04)70065-1","article-title":"Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram","volume":"5","author":"Tahir","year":"2004","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0805","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2190\/PM.38.1.h","article-title":"Serotonergic antidepressants and linezolid: a retrospective chart review and presentation of cases","volume":"38","author":"Lorenz","year":"2008","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0810","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1592\/phco.26.2.269","article-title":"Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature","volume":"26","author":"Clark","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0815","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2146\/ajhp060227","article-title":"Mild serotonin syndrome associated with concurrent linezolid and fluoxetine","volume":"64","author":"Steinberg","year":"2007","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0820","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1176\/appi.psy.46.3.274","article-title":"Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine","volume":"46","author":"Morales","year":"2005","journal-title":"Psychosomatics"},{"issue":"12","key":"10.1016\/j.genhosppsych.2013.03.018_bb0825","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/340710","article-title":"Serotonin syndrome and linezolid","volume":"34","author":"Wigen","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0830","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1345\/aph.1E523","article-title":"Serotonin toxicity associated with concomitant use of linezolid","volume":"39","author":"Bergeron","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0835","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/dkh257","article-title":"Serotonin syndrome due to co-administration of linezolid and venlafaxine","volume":"54","author":"Jones","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0840","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3928\/01477447-20081101-17","article-title":"Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty","volume":"31","author":"Mason","year":"2008","journal-title":"Orthopedics"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0845","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/01.jcp.0000239793.29449.75","article-title":"Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine","volume":"26","author":"Strouse","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0850","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0885066605280825","article-title":"Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient","volume":"20","author":"DeBellis","year":"2005","journal-title":"J Intensive Care Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0855","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jemermed.2007.10.072","article-title":"Antibiotic-induced serotonin syndrome","volume":"40","author":"Miller","year":"2011","journal-title":"J Emerg Med"},{"issue":"1\u20134","key":"10.1016\/j.genhosppsych.2013.03.018_bb0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/DMDI.2010.001","article-title":"Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment","volume":"25","author":"Go","year":"2010","journal-title":"Drug Metabol Drug Interact"},{"issue":"12","key":"10.1016\/j.genhosppsych.2013.03.018_bb0865","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1592\/phco.26.12.1784","article-title":"Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists","volume":"26","author":"Huang","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0870","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/504809","article-title":"Linezolid and serotonergic drug interactions: a retrospective survey","volume":"43","author":"Taylor","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0875","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/jac\/dki368","article-title":"Linezolid-associated serotonin syndrome: what we can learn from cases reported so far","volume":"56","author":"Morales-Molina","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0880","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1086\/503839","article-title":"Serotonin toxicity associated with the use of linezolid: a review of postmarketing data","volume":"42","author":"Lawrence","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0885","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0009-9236(97)90038-2","article-title":"Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole","volume":"62","author":"Kivisto","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0890","first-page":"191","article-title":"Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2","volume":"43","author":"Fuhr","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2013.03.018_bb0895","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/clpt.2008.33","article-title":"The effect of moxifloxacin on QTc and implications for the design of thorough QT studies","volume":"84","author":"Bloomfield","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0900","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.socscimed.2008.01.047","article-title":"The creation of the concept of an antidepressant: an historical analysis","volume":"66","author":"Moncrieff","year":"2008","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0905","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","article-title":"Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis","volume":"38","author":"Amaral","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0910","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jac\/47.5.505","article-title":"Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy","volume":"47","author":"Amaral","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0915","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157489110791233540","article-title":"Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent \"as new use\"","volume":"5","author":"Amaral","year":"2010","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012640","article-title":"The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis","volume":"5","author":"van Soolingen","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0925","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","article-title":"Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines","volume":"17","author":"Viveiros","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0930","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239036","article-title":"Chlorpromazine: a drug potentially useful for treating mycobacterial infections","volume":"38","author":"Crowle","year":"1992","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0935","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/joc.1999.11.3.203","article-title":"In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine","volume":"11","author":"Gadre","year":"1999","journal-title":"J Chemother"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0940","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004850-199805000-00006","article-title":"Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobacterium tuberculosis","volume":"13","author":"Gadre","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb0945","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1378\/chest.35.2.134","article-title":"Clinical experience with ataractic therapy in tuberculous psychiatric patients","volume":"35","author":"Fisher","year":"1959","journal-title":"Dis Chest"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb0950","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0447.1966.tb08827.x","article-title":"Experience with chlormethiazole (Heminevrin) in the treatment of tuberculous alcoholic patients","volume":"192","author":"Levendel","year":"1966","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0955","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2249.2011.04381.x","article-title":"Autophagy in the immune response to tuberculosis: clinical perspectives","volume":"164","author":"Cheallaigh","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.genhosppsych.2013.03.018_bb0960","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmented exposure therapy for obsessive-compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0965","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder","volume":"165","author":"Wilhelm","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2 Suppl 3","key":"10.1016\/j.genhosppsych.2013.03.018_bb0970","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1092852900027255","article-title":"New pharmacotherapeutic approaches to obsessive-compulsive disorder","volume":"14","author":"Figee","year":"2009","journal-title":"CNS Spectr"},{"issue":"1","key":"10.1016\/j.genhosppsych.2013.03.018_bb0975","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-010-1808-9","article-title":"The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder","volume":"210","author":"Albelda","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.genhosppsych.2013.03.018_bb0980","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brat.2010.03.007","article-title":"Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine","volume":"48","author":"Chasson","year":"2010","journal-title":"Behav Res Ther"},{"issue":"11","key":"10.1016\/j.genhosppsych.2013.03.018_bb0985","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.biopsych.2010.07.015","article-title":"A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder","volume":"68","author":"Storch","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2013.03.018_bb0990","first-page":"538","article-title":"Psychiatry and tuberculosis","volume":"73","author":"Fantl","year":"1950","journal-title":"Calif Med"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb0995","first-page":"171","article-title":"Psychosocial dysfunction in tuberculosis patients","volume":"54","author":"Bhatia","year":"2000","journal-title":"Indian J Med Sci"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb1000","first-page":"482","article-title":"The management of tuberculous patients in mental hospitals","volume":"55","author":"Crandell","year":"1958","journal-title":"J Med Soc N J"},{"issue":"2","key":"10.1016\/j.genhosppsych.2013.03.018_bb1005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1378\/chest.24.2.123","article-title":"Development of a psychological program in a tuberculosis hospital","volume":"24","author":"Stewart","year":"1953","journal-title":"Dis Chest"},{"issue":"5","key":"10.1016\/j.genhosppsych.2013.03.018_bb1010","first-page":"565","article-title":"Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients","volume":"10","author":"Fleming","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.genhosppsych.2013.03.018_bb1015","first-page":"278","article-title":"Smoking prolongs the infectivity of tuberculosis","volume":"103","author":"Siddiqui","year":"2010","journal-title":"Ir Med J"},{"issue":"10","key":"10.1016\/j.genhosppsych.2013.03.018_bb1020","doi-asserted-by":"crossref","first-page":"e13339","DOI":"10.1371\/journal.pone.0013339","article-title":"Knowledge, health seeking behavior and perceived stigma towards tuberculosis among tuberculosis suspects in a rural community in southwest Ethiopia","volume":"5","author":"Abebe","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb1025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1471-2458-10-400","article-title":"Prejudice and misconceptions about tuberculosis and HIV in rural and urban communities in Ethiopia: a challenge for the TB\/HIV control program","volume":"10","author":"Deribew","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.genhosppsych.2013.03.018_bb1030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1756-0500-3-249","article-title":"The synergy between TB and HIV co-infection on perceived stigma in Ethiopia","volume":"3","author":"Deribew","year":"2010","journal-title":"BMC Res Notes"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834313000996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834313000996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:59:34Z","timestamp":1715306374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834313000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":206,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0163834313000996"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.03.018","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}